IndraLab

Statements

PSMD14 leads to the deubiquitination of bortezomib. 1 / 1

| 1

reach

"Together with the finding that POH1 inhibition induced a distinctly different change in the ubiquitination profile from bortezomib, this compound may have potential as a treatment modality in patients previously treated with bortezomib."

29134486

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

PSMD14 leads to the deubiquitination of bortezomib. 1 / 1

INDRA sources:

Databases

Reading